Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Beta-blockers: no longer an option for uncomplicated hypertension.

Bangalore S, Kamalakkannan G, Messerli FH.

Curr Cardiol Rep. 2007 Nov;9(6):441-6. Review.

PMID:
17999868
2.

Beta-blockers for hypertension: are they going out of style?

Che Q, Schreiber MJ Jr, Rafey MA.

Cleve Clin J Med. 2009 Sep;76(9):533-42. doi: 10.3949/ccjm.76a.09030. Review.

PMID:
19726558
3.

The Role of Beta-Blockers in the Treatment of Hypertension.

Cruickshank JM.

Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36. Review.

PMID:
27957711
4.

Beta-blockers use for hypertension in the elderly.

Herrera J.

Cardiovasc Hematol Agents Med Chem. 2015;12(3):152-9. Review.

PMID:
25761100
5.

Current place of beta-blockers in the treatment of hypertension.

Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M.

Curr Vasc Pharmacol. 2010 Nov;8(6):733-41. Review.

PMID:
20626337
6.

Cardiovascular protection using beta-blockers: a critical review of the evidence.

Bangalore S, Messerli FH, Kostis JB, Pepine CJ.

J Am Coll Cardiol. 2007 Aug 14;50(7):563-72. Epub 2007 Jul 30. Review.

7.

Current role of beta-blockers in the treatment of hypertension.

Aronow WS.

Expert Opin Pharmacother. 2010 Nov;11(16):2599-607. doi: 10.1517/14656566.2010.482561. Epub 2010 Apr 28. Review.

PMID:
20426702
8.

Current status of β-blockers for the treatment of hypertension: an update.

Chrysant SG, Chrysant GS.

Drugs Today (Barc). 2012 May;48(5):353-66. doi: 10.1358/dot.2012.48.5.1782932. Review.

PMID:
22645723
9.

Use of carvedilol in hypertension: an update.

Leonetti G, Egan CG.

Vasc Health Risk Manag. 2012;8:307-22. doi: 10.2147/VHRM.S31578. Epub 2012 May 18. Review.

10.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
11.

Why beta-blockers should not be used as first choice in uncomplicated hypertension.

De Caterina AR, Leone AM.

Am J Cardiol. 2010 May 15;105(10):1433-8. doi: 10.1016/j.amjcard.2009.12.068. Epub 2010 Mar 30. Review.

PMID:
20451690
12.
13.

Goals of antihypertensive therapy.

McVeigh GE, Flack J, Grimm R.

Drugs. 1995 Feb;49(2):161-75. Review.

PMID:
7729325
14.

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.

Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH.

J Hypertens. 2006 Nov;24(11):2131-41. Review.

PMID:
17053529
15.

Beta-adrenergic antagonists in hypertension: a review of the evidence.

Warmack TS, Estes MA, Heldenbrand S, Franks AM.

Ann Pharmacother. 2009 Dec;43(12):2031-43. doi: 10.1345/aph.1M381. Review.

PMID:
19934392
16.

Long-term safety of antihypertensive therapy.

Grossman E, Messerli FH.

Prog Cardiovasc Dis. 2006 Jul-Aug;49(1):16-25. Review.

PMID:
16867847
17.

Nebivolol: a third-generation beta-blocker for hypertension.

Cheng JW.

Clin Ther. 2009 Mar;31(3):447-62. doi: 10.1016/j.clinthera.2009.03.007. Review.

PMID:
19393838
18.

[Alpha beta-blockers for patients with hypertension].

Mizuta Y, Imaizumi T.

Nihon Rinsho. 2006 Aug;64 Suppl 6:305-9. Review. Japanese. No abstract available.

PMID:
16981560
19.

Vasodilating versus first-generation β-blockers for cardiovascular protection.

Fares H, Lavie CJ, Ventura HO.

Postgrad Med. 2012 Mar;124(2):7-15. doi: 10.3810/pgm.2012.03.2532. Review.

PMID:
22437211
20.

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.

Wong GW, Laugerotte A, Wright JM.

Cochrane Database Syst Rev. 2015 Aug 26;(8):CD007449. doi: 10.1002/14651858.CD007449.pub2. Review.

PMID:
26306578

Supplemental Content

Support Center